2009 SCAI Scientific Sessions Schedule

Here is the page we will use to coordinate filming at SCAI 2009 Filming will occur from Wednesday to Friday (May 6 - May 8).

Click on Date for Detailed Schedule
Wednesday, May 6, 2009

Thursday, May 7, 2009

Friday, May 8, 2009

11:30 AM

 * Event: Press conference
 * Location: Pompeian Ballroom
 * Trial/topic: Late-Breaking Clinical Trial: The Clopidogrel Medco Outcomes Study on the possible effects of clopidogrel and heart burn medications known as PPIs
 * Presenter:

1:00 PM

 * Event: Concurrent Session II- Current DES: What's Different? What's the Same?
 * Location:
 * Trial/topic: DES in 2009: State of the Art Review
 * Presenter: David Cohen, MD

1:15 PM

 * Event: Concurrent Session II- Current DES: What's Different? What's the Same?
 * Location:
 * Trial/topic: Currently Approved Drug-Eluting Stents: Are There Meaningful Differences?
 * Presenter: Donald E. Cutlip, MD, FSCAI

1:30 PM

 * Event: Concurrent Session II- Current DES: What's Different? What's the Same?
 * Location:
 * Trial/topic: DES Marinade: Optimal Pharmacology
 * Presenter: Matthew J. Price, MD

1:45 PM

 * Event: Concurrent Session II- Current DES: What's Different? What's the Same?
 * Location:
 * Trial/topic: Long Term DES Results: Pathologic Lessons
 * Presenter: Renu Vermani, MD

2:00 PM

 * Event: Concurrent Session II- Current DES: What's Different? What's the Same?
 * Location:
 * Trial/topic: Stent Thrombosis: Predictors and Prevention
 * Presenter:

2:15 PM

 * Event: Concurrent Session II- Current DES: What's Different? What's the Same?
 * Location:
 * Trial/topic: Role of Bare Metal Stents in Contemporary Practice
 * Presenter: Spencer B. King, III, MD, FSCAI

2:30 PM

 * Event: Concurrent Session II- Current DES: What's Different? What's the Same?
 * Location:
 * Trial/topic: Managing the DES Patient Having Non-Cardiac Surgery
 * Presenter: Timothy A. Sanborn, MD, FSCAI

3:30 PM

 * Event: Concurrent Session II- Emerging Tech: Stent Pipeline
 * Location:
 * Trial/topic: The Next Wave of Workhorse Drug-Eluting Stents
 * Presenter:

3:45 PM

 * Event: Concurrent Session II- Emerging Tech: Stent Pipeline
 * Location:
 * Trial/topic: Niche Stents: Bifurcation, ostial and Small Vessels/Long Lesions
 * Presenter: Aaron V. Kaplan, MD, FSCAI

4:00 PM

 * Event: Concurrent Session II- Emerging Tech: Stent Pipeline
 * Location:
 * Trial/topic: Strategies to Enhance Endothelial Healing
 * Presenter: Roxana Mehran, MD, FSCAI

4:15 PM

 * Event: Concurrent Session II- Emerging Tech: Stent Pipeline
 * Location:
 * Trial/topic: Beyond Permanent Polymers: Novel Drug Delivery Platforms
 * Presenter: Alexander Abizaid, MD

4:30 PM

 * Event: Concurrent Session II- Emerging Tech: Stent Pipeline
 * Location:
 * Trial/topic: Why have a Permanent Implant: The Bioresorbable Alternative
 * Presenter: Ron Waksman, MD

4:45 PM

 * Event: Concurrent Session II- Emerging Tech: Stent Pipeline
 * Location:
 * Trial/topic: The Road to Approval of Novel Drug-Eluting Stent Devices
 * Presenter: Ashley B Boam

Return to top

8:00 AM

 * Event: Concurrent Session I- PCI: Antithrombotic Therapy
 * Location:
 * Trial/topic: Pharmacology and Mechanisms of Anti-Thrombin Therapy
 * Presenter: Sunil Rao, MD, FSCAI

8:15 AM

 * Event: Concurrent Session I- PCI: Antithrombotic Therapy
 * Location:
 * Trial/topic: Optimal Upstream Anti-Thrombin Therapy
 * Presenter: E. Magnus Ohman, MD, FSCAI

8:30 AM

 * Event: Concurrent Session I- PCI: Antithrombotic Therapy
 * Location:
 * Trial/topic: Why Heparin Still Has a Role in Contemporary PCI
 * Presenter: James P. Zidar, MD, FSCAI

8:45 AM

 * Event: Concurrent Session I- PCI: Antithrombotic Therapy
 * Location:
 * Trial/topic: Bivalrudin: Should it Be the Agent of Choice for All PCI's?
 * Presenter: Frederick Feit, MD

9:00 AM

 * Event: Concurrent Session I- PCI: Antithrombotic Therapy
 * Location:
 * Trial/topic: New Anti-Thrombotic Agents on the Horizon
 * Presenter: Neal S. Kleiman, MD, FSCAI


 * Event: Press conference
 * Location: Pompeian Ballroom
 * Trial/topic: Late-Breaking Clinical Trials: Zilver trial of the first drug-eluting stent for peripheral artery disease and AMADEUS trial on percutaneous mitral valve repair. New expert consensus paper on length of stay following elective percutaneous coronary intervention (PCI)
 * Presenter:

9:15 AM

 * Event: Concurrent Session I- PCI: Antithrombotic Therapy
 * Location:
 * Trial/topic: The Impact of Bleeding on PCI Outcomes
 * Presenter: Steven V. Manoukian, MD, FSCAI

10:15 AM

 * Event: Concurrent Session I- PCI: Antiplatelet Therapy
 * Location:
 * Trial/topic: TRITON: Summary, With New Unpublished Data
 * Presenter: Theodore A. Bass, MD, FSCAI

10:30 AM

 * Event: Concurrent Session I- PCI: Antiplatelet Therapy
 * Location:
 * Trial/topic: How I Believe Cardiologist Should (and Should Not) Integrate Prasugrel into Practice
 * Presenter: Stephen G. Ellis, MD

10:45 AM

 * Event: Concurrent Session I- PCI: Antiplatelet Therapy
 * Location:
 * Trial/topic: High Platelet Reactivity: What, if Anything, Does it Mean?
 * Presenter: Steven R. Steinhubl, MD

11:00 AM

 * Event: Concurrent Session I- PCI: Antiplatelet Therapy
 * Location:
 * Trial/topic: AZD 6140: Summary of What We Know and Can Expect
 * Presenter: Peter B. Berger, MD, FSCAI

11:15 AM

 * Event: Concurrent Session I- PCI: Antiplatelet Therapy
 * Location:
 * Trial/topic: Cangrelor: Summary, and My View of its Future Role
 * Presenter: John J. Young, MD, FSCAI

1:15 PM

 * Event: Concurrent Session I- PCI: Chronic Total Occlusions
 * Location:
 * Trial/topic: Clinical Rationale of Recanalization of CTO
 * Presenter: James R. Margolis, MD

1:30 PM

 * Event: Concurrent Session I- PCI: Chronic Total Occlusions
 * Location:
 * Trial/topic: Role of Pre-Procedural Imaging for CTO
 * Presenter: Bradley H. Strauss, MD

1:45 PM

 * Event: Concurrent Session I- PCI: Chronic Total Occlusions
 * Location:
 * Trial/topic: New Antegrade Strategy: Recanalization of Invisible Micro-Channel
 * Presenter: Gerald Werner, MD

2:00 PM

 * Event: Concurrent Session I- PCI: Chronic Total Occlusions
 * Location:
 * Trial/topic: IVUS Guidance for CTO Recanalization
 * Presenter: David Kandzari, MD, FSCAI

2:15 PM

 * Event: Concurrent Session I- PCI: Chronic Total Occlusions
 * Location:
 * Trial/topic: Retrograde Approach: US Experience
 * Presenter: Craig A. Thompson, MD, FSCAI

2:30 PM

 * Event: Concurrent Session I- PCI: Chronic Total Occlusions
 * Location:
 * Trial/topic: Retrograde Approach: European Experience
 * Presenter: Alfredo R. Galassi, MD, FSCAI

2:45 PM

 * Event: Concurrent Session I- PCI: Chronic Total Occlusions
 * Location:
 * Trial/topic: Updated Retrograde Approach from Japan
 * Presenter: Etuso Tsuchikane, MD, FSCAI

3:00 PM

 * Event: Concurrent Session I- PCI: Chronic Total Occlusions
 * Location:
 * Trial/topic: New Technology for CTO Revascularization
 * Presenter: William L. Lombardi, MD, FSCAI

3:45 PM

 * Event: Concurrent Session I- Debates
 * Location:
 * Trial/topic: Is COURAGE Still Relevant?
 * Presenter: Matthew R. Wolff, MD, FSCAI and Frederick Feit, MD, FSCAI

4:15 PM

 * Event: Concurrent Session I- Debates
 * Location:
 * Trial/topic: Elective PCI without Onsite Surgery is the New Standard of Care
 * Presenter: Michael A. Kutcher, MD, FSCAI and Gregory J. Dehmer, MD, FSCAI

4:45 PM

 * Event: Concurrent Session I- Debates
 * Location:
 * Trial/topic: PCI Should Replace CABG in Most Patients with Multi Vessel Disease
 * Presenter: Antonio Colombo, MD, FSCAI and David R. Holmes, Jr., MD, FSCAI

6:00 PM

 * Event: Interviews for Women in Innovations


 * Location: Tiberius V room of Caesar’s Palace

7:00 PM

 * Topic: Women in Innovations dinner conference


 * Location: Tiberius V room of Caesar’s Palace


 * Presenter: Roxana Mehran


 * Contact: Rebecca Teichgraeber, Associate Director, Education, SCAI, 2400 N St NW, Ste 500, Washington, DC 20037. Direct line: 202.741.9872, Cell:202 360 9962, rebeccat@scai.org

Return to top

8:00 AM

 * Event: Concurrent Session I- What Do We Do Now?
 * Location:
 * Trial/topic: Ideal Systems of Care for Managing STEMI (Outside of Minnesota)
 * Presenter: Timothy D. Henry, MD, FSCAI

8:15 AM

 * Event: Concurrent Session I- What Do We Do Now?
 * Location:
 * Trial/topic: Optimum Pharmacologic Management with Primary PCI for STEMI: How Does HORIZONS Change the Paradigm?
 * Presenter: Gregg W. Stone, MD, FSCAI

8:30 AM

 * Event: Concurrent Session I- What Do We Do Now?
 * Location:
 * Trial/topic: Large Thrombus Burden with STEMI: What Should We Do Now?
 * Presenter: David A. Cox, MD, FSCAI

8:45 AM

 * Event: Concurrent Session I- What Do We Do Now?
 * Location:
 * Trial/topic: Reducing Infarct Size with Primary PCI for STEMI: Can We Find the Holy Grail?
 * Presenter:

9:00 AM

 * Event: Concurrent Session I- What Do We Do Now?
 * Location:
 * Trial/topic: Drug-Eluting versus Bare Metal Stents for STEMI- Does HORIZONS Provide the Answers?
 * Presenter: Peter Casterella, MD

9:15 AM

 * Event: Concurrent Session I- What Do We Do Now?
 * Location:
 * Trial/topic: New Systems of Care for Management of STEMI: Implications for Reimbursement
 * Presenter: Peter Casterella, MD

10:15 AM

 * Event: Main Session- Emerging Therapy: Antiplatelet Drugs
 * Location:
 * Trial/topic: Platelet Physiology and Blockade for Interventionalist
 * Presenter:


 * Event: Concurrent Session I- PCI: Guideline Update
 * Location:
 * Trial/topic: Early Invasive Strategy in UA/NSTEMI: In Whom and When?
 * Presenter: William Boden, MD

10:30 AM

 * Event: Main Session- Emerging Therapy: Antiplatelet Drugs
 * Location:
 * Trial/topic: Do We Need New Antiplatelet Agents?
 * Presenter: C. Michael Gibson, MD


 * Event: Concurrent Session I- PCI: Guideline Update
 * Location:
 * Trial/topic: Facilitated PCI: Is the Issue Closed?
 * Presenter: Stephen G. Ellis, MD

10:45 AM

 * Event: Main Session- Emerging Therapy: Antiplatelet Drugs
 * Location:
 * Trial/topic: Prasugrel
 * Presenter: Dave Morrow, MD


 * Event: Concurrent Session I- PCI: Guideline Update
 * Location:
 * Trial/topic: Pharmaco-Invasive Strategy in STEMI: When and Where?
 * Presenter: Eric R. Bates, MD

11:00 AM

 * Event: Main Session- Emerging Therapy: Antiplatelet Drugs
 * Location:
 * Trial/topic: Reversible P2Y12 Inhibitors
 * Presenter: Theodore A. Bass, MD, FSCAI


 * Event: Concurrent Session I- PCI: Guideline Update
 * Location:
 * Trial/topic: Antiplatelet Therapy: Issues and Concerns
 * Presenter: E. Magnus Ohman, MD, FSCAI

11:15 AM

 * Event: Main Session- Emerging Therapy: Antiplatelet Drugs
 * Location:
 * Trial/topic: Thrombin Receptor Antagonists
 * Presenter:


 * Event: Concurrent Session I- PCI: Guideline Update
 * Location:
 * Trial/topic: Anticoagulant Therapy: Which Agent?
 * Presenter: Sunil Rao, MD, FSCAI

11:30 AM

 * Event: Main Session- Emerging Therapy: Antiplatelet Drugs
 * Location:
 * Trial/topic: Measuring Platelet Reactivity in the Individual Patient: Is it Ready for Prime Time?
 * Presenter: Paul A. Gurble, MD


 * Event: Concurrent Session I- PCI: Guideline Update
 * Location:
 * Trial/topic: Selection of BMS vs DES in Clinical Practice
 * Presenter: William D. Knopf, MD, FSCAI

1:15 PM

 * Event: Concurrent Session I- PCI v. Medicine v. CABG
 * Location:
 * Trial/topic: Who Gets PCI in Current Practice? A Report from the NCDR
 * Presenter: Ralph G. Brindis, MD, FSCAI

1:30 PM

 * Event: Concurrent Session I- PCI v. Medicine v. CABG
 * Location:
 * Trial/topic: Medical Therapy after COURAGE and SYNTAX
 * Presenter: William Boden, MD

1:45 PM

 * Event: Concurrent Session I- PCI v. Medicine v. CABG
 * Location:
 * Trial/topic: Treatment Strategies for CAD: Are We Getting What We Pay For?
 * Presenter: William Weintraub, MD

2:00 PM

 * Event: Concurrent Session I- PCI v. Medicine v. CABG
 * Location:
 * Trial/topic: PCI vs CABG: Registry Data
 * Presenter: William Hui, MbC

2:15 PM

 * Event: Concurrent Session I- PCI v. Medicine v. CABG
 * Location:
 * Trial/topic: PCI vs CABG Meta-Analysis
 * Presenter: Mark A. Hlatky, MD

2:30 PM

 * Event: Concurrent Session I- PCI v. Medicine v. CABG
 * Location:
 * Trial/topic: Workforce of the Near Future: Do We Need More or Fewer Interventionalists to Treat CAD Over the Next Decade?
 * Presenter: Bonnie H. Weiner, MD, FSCAI

2:45 PM

 * Event: Main Session- Practice Changing Trials and Abstracts- STEMI
 * Location:
 * Trial/topic: Facilitated PCI Dead or Alive
 * Presenter: Timothy D. Henry, MD, FSCAI


 * Event: Concurrent Session I- PCI v. Medicine v. CABG
 * Location:
 * Trial/topic: PCI vs Medicine vs CABG Perspective
 * Presenter: Spencer B. King III, MD, FSCAI

2:55 PM

 * Event: Main Session- Practice Changing Trials and Abstracts- STEMI
 * Location:
 * Trial/topic: Anti-Coagulation Strategies During STEMI PCI
 * Presenter: Roxana Mehran, MD, FSCAI

3:05 PM

 * Event: Main Session- Practice Changing Trials and Abstracts- STEMI
 * Location:
 * Trial/topic: DES v BMS
 * Presenter: John S. Douglas, MD, FSCAI

3:45 PM

 * Event: Concurrent Session I: Debates
 * Location:
 * Trial/topic: Facilitated PCI Has a Place?
 * Presenter: Timothy D. Henry, MD, FSCAI and David A. Cox, MD, FSCAI

4:15 PM

 * Event: Concurrent Session I: Debates
 * Location:
 * Trial/topic: IIb/IIIa's are Passe
 * Presenter: Roxana Mehran, MD, FSCAI and Samin K. Sharma, MD, FSCAI

4:45 PM

 * Event: Concurrent Session I: Debates
 * Location:
 * Trial/topic: Thrombectomy is a Must for STEMI
 * Presenter: Mark A. Turco, MD, FSCAI and Harry R. Phillips, MD, FSCAI

Return to top